MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2024 International Congress

    Rapid Cognitive Deterioration and Related Factors in Progressive Supranuclear Palsy: a One-Year Follow-up Study

    XY. Li, G. Tang, FT. Liu, J. Wang (Shanghai, China)

    Objective: Based on a relatively large cohort, we aimed to show the switch of cognitive status in patients with progressive supranuclear palsy (PSP) after one-year follow-up…
  • 2024 International Congress

    A Systematic Review of Transcranial Magnetic Stimulation Clinical Trials in Parkinson’s Disease Patients with Mild Cognitive Impairment

    S. Baveja, R. Rajmohan, N. Phielipp (Orange, USA)

    Objective: This systematic review evaluated the efficacy of transcranial magnetic stimulation (TMS) for mild cognitive impairment in idiopathic Parkinson’s disease (iPD) through review of parallel…
  • 2024 International Congress

    Periodic and Aperiodic EEG Correlates of Cognition in Parkinson’s Disease

    G. Hall-Mcmaster, N. Slater, K-L. Horne, A. Harris, R. Shoorangiz, T. Anderson, N. Pat, T. Melzer, J. Dalrymple-Alford (Christchurch, New Zealand)

    Objective: To examine periodic and aperiodic EEG correlates of cognition in Parkinson’s disease (PD). Background: Quantitative EEG metrics are increasingly used to describe variations in…
  • 2024 International Congress

    “This Abstract Presents the Most Important Scientific ___.” A New Sentence Completion Test for Parkinson’s Disease.

    T. Turner, F. Rodriguez-Porcel (Charleston, USA)

    Objective: In this study we examined psychometric properties of a brief language and executive function measure in People with Parkinson’s (PwP) and related disorders. Background:…
  • 2024 International Congress

    Split-belt Treadmill Training to Rehabilitate Freezing of Gait and Balance in Parkinson’s Disease

    S. Sasikumar, A. Fasano, G. Sorrento (Toronto, Canada)

    Objective: Can repeated exposure to a split-belt treadmill (SBTM) encourage motor learning to improve freezing of gait (FOG) and reduce the number of falls in…
  • 2024 International Congress

    The dementia with Lewy bodies related metabolic brain pattern (DLBRP) – a multicentric validation

    M. Perovnik, U. Simončič, H. Kos, J. Jamšek, M. Kramberger, M. Brendel, V. Camacho, R. Vandenberghe, V. Garibotto, M. Ochoa-Figueroa, A. Padovani, S. Morbelli, D. Ferreira, M. Trošt (Ljubljana, Slovenia)

    Objective: Dementia with Lewy bodies-related pattern (DLBRP) has been identified from the FDG PET brain imaging of DLB patients and healthy controls previously. A multicentric…
  • 2024 International Congress

    How does the PPP2R2B mutation alter neuronal cytoskeletal structure in SCA12

    A. Ganguly, B. Reddy, J. Rungta, S. Choudhury, R. Pal, H. Kumar, S. Chattarji (Kolkata, India)

    Objective: To study the effect of the PPP2R2B mutation on human induced pluripotent stem cell (iPSC) derived neurons in SCA12 patients. Background: SCA12 is an…
  • 2024 International Congress

    Association between use of Furosemide and Risk of Parkinson’s disease

    B. Babar, AM. Tolppanen, S. Hartikainen, M. Tiihonen (Kuopio, Finland)

    Objective: Main objective of study is to check the association between furosemide use and risk of Parkinson's disease (PD) in a Finnish nationwide nested case-control…
  • 2024 International Congress

    The impact of cognitive impairment and Alzheimer’s disease neuropathological changes on gait and falls in Parkinson’s disease

    J. Parmera, P. Cullinane, S. Wrigley, T. Revesz, Z. Jaunmuktane, T. Warner, E. de Pablo-Fernandez (London, United Kingdom)

    Objective: To investigate the association between clinical markers of cognitive impairment, severity, and distribution of Alzheimer's disease neuropathological changes (ADNC) with gait difficulties, freezing of…
  • 2024 International Congress

    Clinical and Neuroimaging Biomarker Predictors of Cognitive Dysfunction In Parkinson’s Disease: A Study Using PPMI Data

    M. Schlindwein, A. Franco, J. Catao, D. Teixeira-Dos-Santos, A. Bieger, T. Hugentobler Schlickmann, L. Angi Souza, C. Mattjie, F. Suzuki, G. Magalhães Pereira, L. Silveira Kupssinskü, L. Vinícius Moura, R. Ravazio, S. Duarte Pinto, M. Bastiani, R. Barros, E. R. Zimmer, A. Schuh (Porto Alegre, Brazil)

    Objective: This study evaluates whether clinical, biological, and neuroimaging baseline markers can predict the onset of significant cognitive-based milestones developed in these cohorts over a…
  • 1
  • 2
  • 3
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley